Episode Details

Recent reports highlight significant economic and political shifts following a Supreme Court ruling that invalidated many of President Trump's previous tariffs, prompting the administration to immediately implement a 10% global levy under a different statute. This trade uncertainty, alongside rising healthcare costs from expired federal insurance subsidies and stubborn inflation, has led the Federal Reserve to pause interest rate cuts. In the corporate sector, Eli Lilly and Novo Nordisk are intensifying their rivalry through major price reductions and new delivery methods for weight-loss drugs. Meanwhile, artificial intelligence continues to reshape the market as Meta secures a massive chip deal with AMD, and major banks like JPMorgan Chase prepare for workforce disruptions. Additionally, political tensions are rising due to allegations of a Department of Justice cover-up regarding past claims against the President found in the Epstein files. These developments coincide with a State of the Union address where the President must address mounting voter concern over affordability and the economy.